Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.114NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.39NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.199NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BY.1.1.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
DK.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BQ.1.11.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.5.2.63NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FM.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GA.4.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GK.1.10.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
EG.10NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GN.1.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
FL.13.3.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
GW.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.424NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.64NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AH.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.327NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.396NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.129NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AK.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
C.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.221.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.224NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.14NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.618NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.458NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.17NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AG.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.258.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
W.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.264.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.21 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.20NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.19NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AT.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.619.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
P.1.12.1 (Gamma)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AZ.2.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.260NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.456NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.160.16NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.4.16 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.1.22NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.70NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.177.42NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.428NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used